Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparative clinical performance of two types of drug-eluting stents with abluminal biodegradable polymer coating: Five-year results of the DESTINY randomized trial.
Prado GFA Jr, Abizaid AAC, Meireles GC, Sarmento-Leite R, Prudente M, Cantarelli M, Dourado AD, Jr JM, Perin MA, Costantini C, Costa R, Costa JR, Chamie D, Campos CM, Ribeiro EE, Lemos PA. Prado GFA Jr, et al. Among authors: cantarelli m. Rev Port Cardiol (Engl Ed). 2021 Feb;40(2):71-76. doi: 10.1016/j.repc.2020.05.017. Epub 2021 Jan 2. Rev Port Cardiol (Engl Ed). 2021. PMID: 33402278 Free article. Clinical Trial. English, Portuguese.
Metallic Limus-Eluting Stents Abluminally Coated with Biodegradable Polymers: Angiographic and Clinical Comparison of a Novel Ultra-Thin Sirolimus Stent Versus Biolimus Stent in the DESTINY Randomized Trial.
Lemos PA, Abizaid AA, Meireles GC, Sarmento-Leite R, Prudente M, Cantarelli M, Dourado AD, Mariani J Jr, Perin MA, Costantini C, Costa RA, Costa JR, Chamie D, Campos CA, Ribeiro E. Lemos PA, et al. Among authors: cantarelli m. Cardiovasc Ther. 2015 Dec;33(6):367-71. doi: 10.1111/1755-5922.12159. Cardiovasc Ther. 2015. PMID: 26352896 Free article. Clinical Trial.
DIRETRIZ DA SOCIEDADE BRASILEIRA DE CARDIOLOGIA E DA SOCIEDADE BRASILEIRA DE HEMODINÂMICA E CARDIOLOGIA INTERVENCIONISTA SOBRE INTERVENÇÃO CORONÁRIA PERCUTÂNEA.
Feres F, Costa RA, Siqueira D, Costa JR Jr, Chamié D, Staico R, Chaves ÁJ, Abizaid A, Marin-Neto JA, Rassi A Jr, Botelho R, Alves CMR, Saad JA, Mangione JA, Lemos PA, Quadros AS, Queiroga MAC, Cantarelli MJC, Figueira HR. Feres F, et al. Arq Bras Cardiol. 2017 Jun;109(1 Suppl 1):1-81. doi: 10.5935/abc.20170111. Arq Bras Cardiol. 2017. PMID: 28792984 Free article. Review. Portuguese. No abstract available.
Pregnancy-associated spontaneous coronary artery dissection: insights from a case series of 13 patients.
Cade JR, Szarf G, de Siqueira ME, Chaves Á, Andréa JC, Figueira HR, Gomes MM Jr, Freitas BP, Filgueiras Medeiros J, Dos Santos MR, Fiorotto WB, Daige A, Gonçalves R, Cantarelli M, Alves CM, Echenique L, de Brito FS Jr, Perin MA, Born D, Hecht H, Caixeta A. Cade JR, et al. Among authors: cantarelli m. Eur Heart J Cardiovasc Imaging. 2017 Jan;18(1):54-61. doi: 10.1093/ehjci/jew021. Epub 2016 Feb 28. Eur Heart J Cardiovasc Imaging. 2017. PMID: 26928981
Percutaneous Coronary Intervention in Chronic Total Occlusion.
Ybarra LF, Cantarelli MJC, Lemke VMG, Quadros AS. Ybarra LF, et al. Among authors: cantarelli mjc. Arq Bras Cardiol. 2018 May;110(5):476-483. doi: 10.5935/abc.20180077. Arq Bras Cardiol. 2018. PMID: 29898046 Free PMC article. Review.
Acetylcysteine for the prevention of renal outcomes in patients with diabetes mellitus undergoing coronary and peripheral vascular angiography: a substudy of the acetylcysteine for contrast-induced nephropathy trial.
Berwanger O, Cavalcanti AB, Sousa AM, Buehler A, Castello-Júnior HJ, Cantarelli MJ, Mangione JA, Bergo RR, São Thiago LE, Nunes PM, da Motta PA, Kodama A, Victor E, Carvalho VO, Sousa JE; Acetylcysteine for Contrast-Induced Nephropathy Trial Investigators. Berwanger O, et al. Among authors: cantarelli mj. Circ Cardiovasc Interv. 2013 Apr;6(2):139-45. doi: 10.1161/CIRCINTERVENTIONS.112.000149. Epub 2013 Apr 9. Circ Cardiovasc Interv. 2013. PMID: 23572490 Clinical Trial.
Overview of Percutaneous Coronary Interventions for Chronic Total Occlusions Treated at Brazilian Centers Participating in the LATAM CTO Registry.
Silva ACBD, Paula JET, Campos CM, Ribeiro MH, Martins Filho E, Oliveira MDP, Côrtes LA, Abelin AP, Zukowski CN, Martinelli GC, Brito FS, Muniz AJ, Cantarelli MJC, Andrade PB, Medeiros CR, Falcão BAA, Fuchs FC, Silva LS, Fattah T, Degrazia RC, Mangione JA, Bezerra CG, Baradel S, Silveira JB, Ybarra LF, Weillenmann D, Gottschall C, Lemke V, Silva FRD, Schmidt MM, Belli KC, Oliveira PP, Quadros AS. Silva ACBD, et al. Among authors: cantarelli mjc. Arq Bras Cardiol. 2023 May 1;120(4):e20210462. doi: 10.36660/abc.20210462. eCollection 2023. Arq Bras Cardiol. 2023. PMID: 37132671 Free PMC article. English, Portuguese.
Five-year cardiovascular outcomes in patients with chronic myeloid leukemia treated with imatinib, dasatinib, or nilotinib: A cohort study using data from a large multinational collaborative network.
Nunes RAB, Neves PDMM, da Costa LMA, Bachour P, Cantarelli MJC, Oliveira GBF, Avezum Á Jr. Nunes RAB, et al. Among authors: cantarelli mjc. Front Cardiovasc Med. 2023 Feb 7;10:888366. doi: 10.3389/fcvm.2023.888366. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 36824461 Free PMC article.
67 results